67 related articles for article (PubMed ID: 24283757)
1. Increased risk for bone loss in women with systemic sclerosis: a comparative study with rheumatoid arthritis.
Kilic G; Kilic E; Akgul O; Ozgocmen S
Int J Rheum Dis; 2016 Apr; 19(4):405-11. PubMed ID: 24283757
[TBL] [Abstract][Full Text] [Related]
2. Effect of Disease-related Variables on Bone Mineral Density in Patients with Rheumatoid Arthritis.
Naik S; Sonawale A; Sonawale K; Goyal A
J Assoc Physicians India; 2024 Jan; 72(1):47-50. PubMed ID: 38736074
[TBL] [Abstract][Full Text] [Related]
3. Bone mass and mineral metabolism in HIV+ postmenopausal women.
Yin M; Dobkin J; Brudney K; Becker C; Zadel JL; Manandhar M; Addesso V; Shane E
Osteoporos Int; 2005 Nov; 16(11):1345-52. PubMed ID: 15754081
[TBL] [Abstract][Full Text] [Related]
4. Machine learning to characterize bone biomarkers profile in rheumatoid arthritis.
Adami G; Fassio A; Rossini M; Benini C; Bixio R; Rotta D; Viapiana O; Gatti D
Front Immunol; 2023; 14():1291727. PubMed ID: 38022514
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and associated factors of osteoporosis in female patients with rheumatoid arthritis.
Mobini M; Kashi Z; Ghobadifar A
Caspian J Intern Med; 2012; 3(3):447-50. PubMed ID: 24009912
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density loss in postmenopausal onset rheumatoid arthritis is not greater than premenopausal onset disease.
Heidari B; Heidari P
Caspian J Intern Med; 2014; 5(4):213-8. PubMed ID: 25489432
[TBL] [Abstract][Full Text] [Related]
7. Severity and impact of digestive impairment perceived by patients with systemic sclerosis: a cross-sectional study.
Cano-García L; Redondo-Rodríguez R; Mena-Vázquez N; Manrique-Arija S; García-Studer A; Ortiz-Marquez F; Borregón-Garrido P; Fernández-Nebro A
BMJ Open; 2024 Apr; 14(4):e083419. PubMed ID: 38684244
[TBL] [Abstract][Full Text] [Related]
8. Assessment of skin involvement in systemic sclerosis.
Kumánovics G; Péntek M; Bae S; Opris D; Khanna D; Furst DE; Czirják L
Rheumatology (Oxford); 2017 Sep; 56(suppl_5):v53-v66. PubMed ID: 28992173
[TBL] [Abstract][Full Text] [Related]
9. Correlation of serum matrix metalloproteinase 3 with osteoporosis in patients of postmenopausal rheumatoid arthritis.
Ji R; Yang L; Shi G; Sun J; Cao P
Hum Immunol; 2024 May; 85(3):110807. PubMed ID: 38701721
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of osteoporotic fractures in patients with systemic sclerosis: a nationwide population-based study.
Lai CC; Wang SH; Chen WS; Liu CJ; Chen TJ; Lee PC; Chang YS
Ann Rheum Dis; 2015 Jul; 74(7):1347-52. PubMed ID: 24532679
[TBL] [Abstract][Full Text] [Related]
11. Correlation between Trabecular Bone Score and Homocysteine Level in Rheumatoid Arthritis Patients on Anti-TNF Inhibitors.
Ioniță-Radu F; Nicolau IN; Petrache OG; Groșeanu ML; Bojincă VC; Negru MM; Bucurică S; Anghel D
Life (Basel); 2024 Apr; 14(4):. PubMed ID: 38672734
[TBL] [Abstract][Full Text] [Related]
12. High prevalence and risk factors for osteoporosis in 1839 patients with systemic sclerosis: a systematic review and meta-analysis.
Tu X; Li C; Zhuang M; Liu L; Xu C; Wang J
Clin Rheumatol; 2023 Apr; 42(4):1087-1099. PubMed ID: 36474110
[TBL] [Abstract][Full Text] [Related]
13. Relationship between ectopic calcifications and bone fragility depicted on computed tomography scan in 70 patients with systemic sclerosis.
Fauny M; Bauer E; Allado E; Albuisson E; Deibener J; Chabot F; Mandry D; Huttin O; Chary-Valckenaere I; Loeuille D
J Scleroderma Relat Disord; 2022 Oct; 7(3):224-233. PubMed ID: 36211200
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors for bone loss in Southern Chinese with rheumatic diseases.
Hu Z; Xu S; Lin H; Ni W; Yang Q; Qi J; Du K; Gu J; Lin Z
BMC Musculoskelet Disord; 2020 Jun; 21(1):416. PubMed ID: 32605558
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of fracture risk and bone mineral density in patients with systemic sclerosis.
Chen J; Lei L; Pan J; Zhao C
Clin Rheumatol; 2020 Apr; 39(4):1181-1189. PubMed ID: 31838641
[TBL] [Abstract][Full Text] [Related]
16. Comorbidity burden in systemic sclerosis: beyond disease-specific complications.
Pagkopoulou E; Arvanitaki A; Daoussis D; Garyfallos A; Kitas G; Dimitroulas T
Rheumatol Int; 2019 Sep; 39(9):1507-1517. PubMed ID: 31300848
[TBL] [Abstract][Full Text] [Related]
17. Distal radius and tibia bone microarchitecture impairment in female patients with diffuse systemic sclerosis.
Sampaio-Barros MM; Alvarenga JC; Takayama L; Assad APL; Sampaio-Barros PD; Pereira RMR
Osteoporos Int; 2019 Aug; 30(8):1679-1691. PubMed ID: 31030240
[TBL] [Abstract][Full Text] [Related]
18. Vertebral fracture prevalence and measurement of the scanographic bone attenuation coefficient on CT-scan in patients with systemic sclerosis.
Fauny M; Bauer E; Albuisson E; Perrier-Cornet J; Deibener J; Chabot F; Mandry D; Huttin O; Chary-Valckenaere I; Loeuille D
Rheumatol Int; 2018 Oct; 38(10):1901-1910. PubMed ID: 30132216
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis.
Chen C; Wang D; Moshaverinia A; Liu D; Kou X; Yu W; Yang R; Sun L; Shi S
Cell Res; 2017 Apr; 27(4):559-577. PubMed ID: 28106077
[TBL] [Abstract][Full Text] [Related]
20. mTOR inhibition rescues osteopenia in mice with systemic sclerosis.
Chen C; Akiyama K; Wang D; Xu X; Li B; Moshaverinia A; Brombacher F; Sun L; Shi S
J Exp Med; 2015 Jan; 212(1):73-91. PubMed ID: 25534817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
